Antagonism of EGFR and HER3 Enhances the Response to Inhibitors of the PI3K-Akt Pathway in Triple-Negative Breast CancerJessica J. Tao, Maurizio Scaltriti, Nina Radosevic‐Robin et al.|Science Signaling|2014Cited by 166
Therapeutic Trial of Metformin and Bortezomib in a Mouse Model of Tuberous Sclerosis Complex (TSC)Neil Auricchio, David J. Kwiatkowski|PLoS ONE|2012Cited by 28